{"entity":{"type":"insider","cik":"0002045943","url":"/insider/0002045943","json_url":"/insider/0002045943.json","name":"Abate Kristin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2025-03-06","last":"2026-05-15","span_basis":"filed_date"},"name_variants":[{"name":"Abate Kristin","source":"filing","n_filings":9,"first_seen":"2025-03-06","last_seen":"2026-05-15"}],"transactions":[{"id":6234293,"accession":"0001193125-26-226616","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-226616","line_url":"/filing/0001193125-26-226616#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0002045943","owner_name":"Abate Kristin","owner_display_name":"Abate Kristin","owner_url":"/insider/0002045943","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53.0,"shares_display":"53","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":503.5,"total_display":"503.50","total_whole":"504","shares_owned_after":23801.0,"shares_owned_after_display":"23,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-15","scope":"insider"},{"id":5913471,"accession":"0002045943-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002045943-26-000003","line_url":"/filing/0002045943-26-000003#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0002045943","owner_name":"Abate Kristin","owner_display_name":"Abate Kristin","owner_url":"/insider/0002045943","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":559.0,"shares_display":"559","price_per_share":9.4095,"price_display":"9.41","price_state":"stated","total_value":5259.9105,"total_display":"5,259.91","total_whole":"5,260","shares_owned_after":22063.0,"shares_owned_after_display":"22,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":6228473,"accession":"0001193125-26-029599","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-029599","line_url":"/filing/0001193125-26-029599#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0002045943","owner_name":"Abate Kristin","owner_display_name":"Abate Kristin","owner_url":"/insider/0002045943","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":7.03,"price_display":"7.03","price_state":"stated","total_value":351.5,"total_display":"351.50","total_whole":"352","shares_owned_after":22622.0,"shares_owned_after_display":"22,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-28","filed_date":"2026-01-29","scope":"insider"},{"id":5904354,"accession":"0001193125-26-019428","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-019428","line_url":"/filing/0001193125-26-019428#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0002045943","owner_name":"Abate Kristin","owner_display_name":"Abate Kristin","owner_url":"/insider/0002045943","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":265.0,"shares_display":"265","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":1579.4,"total_display":"1,579.40","total_whole":"1,579","shares_owned_after":22580.0,"shares_owned_after_display":"22,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-21","filed_date":"2026-01-22","scope":"insider"},{"id":4372190,"accession":"0001193125-25-230359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-230359","line_url":"/filing/0001193125-25-230359#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0002045943","owner_name":"Abate Kristin","owner_display_name":"Abate Kristin","owner_url":"/insider/0002045943","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":362.0,"shares_display":"362","price_per_share":6.296,"price_display":"6.30","price_state":"stated","total_value":2279.152,"total_display":"2,279.15","total_whole":"2,279","shares_owned_after":10046.0,"shares_owned_after_display":"10,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-01","filed_date":"2025-10-03","scope":"insider"},{"id":4092811,"accession":"0001193125-25-205038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-205038","line_url":"/filing/0001193125-25-205038#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0002045943","owner_name":"Abate Kristin","owner_display_name":"Abate Kristin","owner_url":"/insider/0002045943","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23.0,"shares_display":"23","price_per_share":6.43,"price_display":"6.43","price_state":"stated","total_value":147.89,"total_display":"147.89","total_whole":"148","shares_owned_after":10408.0,"shares_owned_after_display":"10,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-16","scope":"insider"},{"id":4646334,"accession":"0002045943-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0002045943-25-000004","line_url":"/filing/0002045943-25-000004#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0002045943","owner_name":"Abate Kristin","owner_display_name":"Abate Kristin","owner_url":"/insider/0002045943","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12.0,"shares_display":"12","price_per_share":6.78,"price_display":"6.78","price_state":"stated","total_value":81.36,"total_display":"81.36","total_whole":"81","shares_owned_after":9463.0,"shares_owned_after_display":"9,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-04","scope":"insider"},{"id":4497143,"accession":"0000950170-25-097965","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-097965","line_url":"/filing/0000950170-25-097965#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0002045943","owner_name":"Abate Kristin","owner_display_name":"Abate Kristin","owner_url":"/insider/0002045943","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":238.0,"shares_display":"238","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":952.0,"total_display":"952.00","total_whole":"952","shares_owned_after":9475.0,"shares_owned_after_display":"9,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-22","filed_date":"2025-07-23","scope":"insider"},{"id":4712240,"accession":"0000950170-25-034662","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-034662","line_url":"/filing/0000950170-25-034662#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0002045943","owner_name":"Abate Kristin","owner_display_name":"Abate Kristin","owner_url":"/insider/0002045943","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":571.0,"shares_display":"571","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":3591.59,"total_display":"3,591.59","total_whole":"3,592","shares_owned_after":9713.0,"shares_owned_after_display":"9,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Officer (Chief Accounting Officer)","n_filings":9,"first_seen":"2025-03-06","last_seen":"2026-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002045943","retrieved_at":"2026-08-23T07:16:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}